BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33109275)

  • 1. Trajectories of subjective cognitive decline, and the risk of mild cognitive impairment and dementia.
    Liew TM
    Alzheimers Res Ther; 2020 Oct; 12(1):135. PubMed ID: 33109275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia.
    Liew TM
    Alzheimers Res Ther; 2020 Sep; 12(1):107. PubMed ID: 32917264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis.
    Aye S; Bouteloup V; Tate A; Wimo A; Handels R; Jean D; Winblad B; Jönsson L
    Alzheimers Res Ther; 2023 Nov; 15(1):200. PubMed ID: 37968734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression, subjective cognitive decline, and the risk of neurocognitive disorders.
    Liew TM
    Alzheimers Res Ther; 2019 Aug; 11(1):70. PubMed ID: 31399132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective Cognitive Decline: Level of Risk for Future Dementia and Mild Cognitive Impairment, a Meta-Analysis of Longitudinal Studies.
    Pike KE; Cavuoto MG; Li L; Wright BJ; Kinsella GJ
    Neuropsychol Rev; 2022 Dec; 32(4):703-735. PubMed ID: 34748154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes.
    Jones JD; Uribe C; Bunch J; Thomas KR
    J Neurol; 2021 Jan; 268(1):337-345. PubMed ID: 32804281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The criteria used to rule out mild cognitive impairment impact dementia incidence rates in subjective cognitive decline.
    Whitfield T; Chouliaras L; Morrell R; Rubio D; Radford D; Marchant NL; Walker Z
    Alzheimers Res Ther; 2024 Jun; 16(1):142. PubMed ID: 38943160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of stable and unstable patterns of subjective cognitive decline - results from the Leipzig Longitudinal Study of the Aged (LEILA75+).
    Roehr S; Villringer A; Angermeyer MC; Luck T; Riedel-Heller SG
    BMC Geriatr; 2016 Nov; 16(1):180. PubMed ID: 27814674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Subjective Cognitive Decline With Progression to Dementia in a Cognitively Unimpaired Multiracial Community Sample.
    Chapman S; Rentería MA; Dworkin JD; Garriga SM; Barker MS; Avila-Rieger J; Gonzalez C; Joyce JL; Vonk JMJ; Soto E; Manly JJ; Brickman AM; Mayeux RP; Cosentino SA
    Neurology; 2023 Mar; 100(10):e1020-e1027. PubMed ID: 36450605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.
    Scharre DW; Chang SI; Nagaraja HN; Wheeler NC; Kataki M
    Alzheimers Res Ther; 2021 Dec; 13(1):192. PubMed ID: 34872596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
    Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study.
    Liew TM
    Aust N Z J Psychiatry; 2022 Dec; 56(12):1664-1675. PubMed ID: 35229693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective Cognitive Decline as a predictor of Frailty in older adults: Hellenic Longitudinal Investigation of Aging and Diet study (HELIAD).
    Margioti E; Scarmeas N; Yannakoulia M; Dardiotis E; Hadjigeorgiou G; Sakka P; Ntanasi E; Aretouli E; Kosmidis MH
    J Frailty Aging; 2023; 12(3):198-207. PubMed ID: 37493380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body Mass Index Trajectories Preceding Incident Mild Cognitive Impairment and Dementia.
    Guo J; Wang J; Dove A; Chen H; Yuan C; Bennett DA; Xu W
    JAMA Psychiatry; 2022 Dec; 79(12):1180-1187. PubMed ID: 36287554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Cerman J; Andel R; Laczo J; Vyhnalek M; Nedelska Z; Mokrisova I; Sheardova K; Hort J
    Curr Alzheimer Res; 2018; 15(3):219-228. PubMed ID: 29165083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.
    Fernández-Blázquez MA; Ávila-Villanueva M; Maestú F; Medina M
    J Alzheimers Dis; 2016 Mar; 52(1):271-81. PubMed ID: 27060949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.
    Eikelboom WS; van den Berg E; Singleton EH; Baart SJ; Coesmans M; Leeuwis AE; Teunissen CE; van Berckel BNM; Pijnenburg YAL; Scheltens P; van der Flier WM; Ossenkoppele R; Papma JM
    Neurology; 2021 Sep; 97(13):e1276-e1287. PubMed ID: 34413181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study on quality of life along the spectrum of Alzheimer's disease.
    Mank A; Rijnhart JJM; van Maurik IS; Jönsson L; Handels R; Bakker ED; Teunissen CE; van Berckel BNM; van Harten AC; Berkhof J; van der Flier WM
    Alzheimers Res Ther; 2022 Sep; 14(1):132. PubMed ID: 36109800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.